Skip to main content
. 2016 Jan 5;129(1):8–14. doi: 10.4103/0366-6999.172548

Figure 1.

Figure 1

Association G-protein β-polypeptide 3 C825T genetic polymorphism with blood pressure response to telmisartan. Decrease in diastolic blood pressure, (a) systolic blood pressure, (b) and mean arterial pressure (c) in essential hypertension patients with different G-protein β-polypeptide 3 C825T genotype after telmisartan therapy for 4 weeks.